PATRICIA PASILLAS CARDENAS: Open Payments
NPI 1447972641 · GENOA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$689 in 30 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $104 · 2025 $689
Food & beverage: $689
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $105 |
| Otsuka America Pharmaceutical, Inc. | 4 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $86 |
| Lundbeck LLC | 4 | $81 |
| Alkermes, Inc. | 3 | $66 |
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| Neurocrine BioSciences, Inc. | 1 | $33 |
| Almatica Pharma LLC | 1 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: REXULTI, VRAYLAR, CAPLYTA, AUSTEDO XR, Jornay PM, LYBALVI, INGREZZA, LOREEV XR.
Industry payments across IL — which companies pay providers there.
